3Suppliers
7Customers
2Debt Items
20Related Chains

Source-Backed Evidence Depth

Exelixis, Inc. (EXEL) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

15Total relationships
4Distinct source URLs
3High confidence
0.743Average confidence
2026-11-02Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Exelixis, Inc. Suppliers

TickerNameConfidenceEvidence
FMCKI Federal Home Loan Mortgage Corporation 72% Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten…

Exelixis, Inc. Customers

TickerNameConfidenceEvidence
FMCKI Federal Home Loan Mortgage Corporation 72% Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten…
TKPHF Takeda Pharmaceutical Company Limited 72% Contract liabilities are primarily related to deferred revenues from Ipsen Pharma SAS (Ipsen) and Takeda Pharmaceutical Company Limited (Takeda).

Exelixis, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
EXEL-DEBT Debt stack $189.1M 90% Market cache reports total debt of $189.1M.
EXEL-DEBT-9411 Xbrl Convertible 90% xbrl convertible detail from xbrl 2016-12-31.

Exelixis, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Exelixis, Inc..

Exelixis, Inc. Ownership

HolderNameConfidenceEvidence
EXEL-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 708 tracked holders.
TKPHF Takeda Pharmaceutical Company Limited 62% Reverse search: TKPHF 20-F (2026-06-17) mentions 'Exelixis' in partner context. Excerpt: nd other hematological cancers. If exercised, the option would allow Takeda to license global rights to develo…
TAK TAK 62% Reverse search: TAK 20-F (2025-06-25) mentions 'Exelixis' in partner context. Excerpt: tinib in all territories outside of mainland China, Hong Kong, Macau, Taiwan and Russia. Crescendo Biologics U.K…

Exelixis, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CVS CVS Health Corporation 100.00 1 ['customer']
FNMAH FEDERAL NATIONAL MORTGAGE ASSOCIATION FANNIE MAE 100.00 1 ['customer', 'supplier']
MCK McKesson Corporation 100.00 1 ['customer']
CAH Cardinal Health, Inc. 100.00 1 ['customer']
FMCKI Federal Home Loan Mortgage Corporation 100.00 1 ['customer', 'supplier']
TKPHF Takeda Pharmaceutical Company Limited 100.00 1 ['customer', 'ownership']
FNMAS Federal National Mortgage Association 100.00 1 ['customer', 'supplier']
AXSM Axsome Therapeutics, Inc. 50.00 2
CWK Cushman & Wakefield Limited 50.00 2
BPOPM POPULAR, INC. 50.00 2
FSBW FS Bancorp, Inc. 50.00 2
FCNCA First Citizens BancShares, Inc. 50.00 2
CBK Commercial Bancgroup, Inc. 50.00 2
BNS The Bank of Nova Scotia 50.00 2
FOA Finance of America Companies Inc. 50.00 2
EMMA Emmaus Life Sciences, Inc. 50.00 2
ACT Enact Holdings, Inc. 50.00 2
COHN Cohen & Company Inc. 50.00 2
FDBC Fidelity D & D Bancorp, Inc. 50.00 2
FKYS First Keystone Corporation 50.00 2
🔐
EXEL
Unlock EXEL Supply Chain Data
Verified relationships include:
FMCKIFederal Home Loan Mortgag…Supplier72%
FNMAHFNMAHSupplier72%
CAHCardinal Health, Inc.Customer72%
CVSCVS Health CorporationCustomer72%
+11 more relationships locked
Subscribe, View plans →